The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cefotaxime Netpharmalab 1g Powder for solution for injection or infusion

Netpharmalab Consulting Services S. L.PA22665/001/001

Main Information

Trade NameCefotaxime Netpharmalab 1g Powder for solution for injection or infusion
Active SubstancesCefotaxime
Dosage FormPowder for solution for injection/infusion
Licence HolderNetpharmalab Consulting Services S. L.
Licence NumberPA22665/001/001

Group Information

ATC CodeJ01DD Third-generation cephalosporins
J01DD01 cefotaxime


License statusAuthorised
Licence Issued06/04/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back